EA010910B1 - Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции - Google Patents

Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции Download PDF

Info

Publication number
EA010910B1
EA010910B1 EA200600471A EA200600471A EA010910B1 EA 010910 B1 EA010910 B1 EA 010910B1 EA 200600471 A EA200600471 A EA 200600471A EA 200600471 A EA200600471 A EA 200600471A EA 010910 B1 EA010910 B1 EA 010910B1
Authority
EA
Eurasian Patent Office
Prior art keywords
pills
filtrate
ethanol
parts
aspirin
Prior art date
Application number
EA200600471A
Other languages
English (en)
Russian (ru)
Other versions
EA200600471A1 (ru
Inventor
Ксицзунь Ян
Наифэнг Ву
Чжэнглянг Йе
Ксу Ли
Чжиксинь Гуо
На Чжао
Original Assignee
Тианцзинь Тейсли Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34621020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA010910(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNB031552757A external-priority patent/CN100391486C/zh
Priority claimed from CNB2004100198381A external-priority patent/CN100411641C/zh
Application filed by Тианцзинь Тейсли Фармасьютикал Ко., Лтд. filed Critical Тианцзинь Тейсли Фармасьютикал Ко., Лтд.
Publication of EA200600471A1 publication Critical patent/EA200600471A1/ru
Publication of EA010910B1 publication Critical patent/EA010910B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200600471A 2003-08-28 2004-08-26 Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции EA010910B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB031552757A CN100391486C (zh) 2003-08-28 2003-08-28 复方丹参滴丸在制备治疗阿司匹林抵抗性心血管疾病的药物中的应用
CNB2004100198381A CN100411641C (zh) 2004-06-30 2004-06-30 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
PCT/CN2004/000989 WO2005049058A1 (en) 2003-08-28 2004-08-26 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases

Publications (2)

Publication Number Publication Date
EA200600471A1 EA200600471A1 (ru) 2006-08-25
EA010910B1 true EA010910B1 (ru) 2008-12-30

Family

ID=34621020

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600471A EA010910B1 (ru) 2003-08-28 2004-08-26 Лечение устойчивости к аспирину с использованием radix salviae miltiorrhizae, его экстракта и композиции

Country Status (13)

Country Link
US (2) US20070071837A1 (enExample)
EP (1) EP1658879B1 (enExample)
JP (1) JP2007504099A (enExample)
KR (1) KR101210405B1 (enExample)
AU (1) AU2004290484B8 (enExample)
CA (1) CA2537300C (enExample)
DK (1) DK1658879T3 (enExample)
EA (1) EA010910B1 (enExample)
ES (1) ES2405599T3 (enExample)
MY (1) MY143282A (enExample)
NO (1) NO335203B1 (enExample)
PT (1) PT1658879E (enExample)
WO (1) WO2005049058A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384878T3 (es) * 2003-11-07 2012-07-13 Basf Beauty Care Solutions S.A.S. Uso cosmético de un extracto de la fruta de Schisandra chinensis
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
GB2439046B (en) * 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
WO2010111935A1 (zh) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 一种新的丹酚酸化合物l、其制备方法和用途
US20120148685A1 (en) * 2009-06-10 2012-06-14 Engergy4Life AG Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
CN102160872A (zh) * 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
CN103099896B (zh) * 2013-01-06 2014-10-01 车艳艳 治疗心脑血管疾病的药茶
CN103169777B (zh) * 2013-02-07 2014-09-10 江苏七○七天然制药有限公司 一种治疗心血管疾病的中药胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
AU6224200A (en) * 1999-10-25 2001-05-08 Colorado Coagulation Consultants Thromboxane B2 metabolite and methods for regulating aspirin-related platelet action
JP2001354579A (ja) * 2000-06-15 2001-12-25 Lion Corp 抗炎症化粧料
AU2002246730B2 (en) * 2000-12-22 2006-09-07 Tasly Pharmaceutical Group Co., Ltd Herbal composition for angina pectoris, method to prepare same and uses thereof
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Citation of document, with indication, where appropriate, of the relevant passages (The People's Republic of China Pharmacopoeia) Version 2000, Part One, Page 518-519 "Fufang Danshen Pian" *
Lishizhen Medicine and Materia Medica Research, Volume 12, 2001. Liuxiaoqing et al., "The Summary of Fufang Danshen Formulations Reseach", page 474-475 *

Also Published As

Publication number Publication date
EP1658879A1 (en) 2006-05-24
AU2004290484B2 (en) 2010-03-25
HK1092090A1 (en) 2007-02-02
US20070071837A1 (en) 2007-03-29
EP1658879A4 (en) 2008-11-26
EA200600471A1 (ru) 2006-08-25
WO2005049058A8 (en) 2005-08-11
AU2004290484B8 (en) 2010-05-13
KR20070017944A (ko) 2007-02-13
AU2004290484A1 (en) 2005-06-02
DK1658879T3 (da) 2013-05-13
NO20060832L (no) 2006-02-21
JP2007504099A (ja) 2007-03-01
MY143282A (en) 2011-04-15
EP1658879B1 (en) 2013-02-20
NO335203B1 (no) 2014-10-20
CA2537300C (en) 2013-07-30
PT1658879E (pt) 2013-04-08
CA2537300A1 (en) 2005-06-02
WO2005049058A1 (en) 2005-06-02
US20080305189A1 (en) 2008-12-11
KR101210405B1 (ko) 2012-12-10
ES2405599T3 (es) 2013-05-31

Similar Documents

Publication Publication Date Title
JP4657714B2 (ja) 心疾患用の組成物、その組成物を調製する方法、及びそれらの使用。
CN103327992B (zh) 用于预防或治疗炎性疾病的包含络石藤提取物和牡丹皮提取物的药物组合物以及制备该药物组合物的方法
JP2018505155A (ja) 心血管疾患及び脳血管疾患又は痴呆を予防又は治療するための中国医薬組成物、並びにこれらの調製方法及び使用
US20080305189A1 (en) Treatment of aspirin resistance with radix salviae miltiorrhizae, its extract and composition
MX2011003647A (es) Pildora por goteo para tratar cardiopatia coronaria y preparacion de la misma.
CN109771431A (zh) 和厚朴酚衍生物的新用途
US6329000B1 (en) Extract of pine needle and the use thereof
CN101647856A (zh) 一种治疗冠心病的药物及其制备方法
KR100601390B1 (ko) 혼합 생약재를 이용한 비만 억제용 조성물
JP2007504099A5 (enExample)
CN100467025C (zh) 积雪草总苷、积雪草苷或羟基积雪草苷在制备防治心、脑血管疾病药物中的用途
CN1923227B (zh) 一种用于治疗缺血性心脑血管疾病的中药制剂
CN101099753A (zh) 救必应总皂苷的制备方法及应用
CN1883585B (zh) 治疗动脉粥样硬化的药物组合物及其制备方法
CN107998385A (zh) 水蛭素作为防治高尿酸血症药物的用途
CN102160889B (zh) 姜花地上部分的提取物和组合物与其用途
US11883452B2 (en) Use of combination or composition of Radix et Rhizoma Notoginseng and aspirin
CN100502937C (zh) 一种治疗心血管疾病的中药组合物及其制备方法
CN100531740C (zh) 一种辅助防治心、脑血管疾病的保健品
CN104587047B (zh) 一种用于治疗心脑血管疾病的中药组合物
CN1299741C (zh) 一种治疗冠心病的中药制剂及其制备方法
TWI391142B (zh) 丹參、其提取物及組成物對阿斯匹靈抵抗的治療應用
CN100411641C (zh) 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
CN1857293A (zh) 一种含有野黄芩苷和芍药苷的药用组合物
CN102579572A (zh) 救心滴丸生产工艺

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU